Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
CMS Extends Medicares Short-Term Bridge Program for GLP-1 Obesity Drug Coverage The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on January 1, 2027
2 Mechanisms of metformin alleviating anovulatory infertility in polycystic ovary syndrome For females of childbearing age, the most significant consequence of PCOS is infertility, for which the pathogenesis is still unclear
For prescribers in dermatology and aesthetic medicine, these peptides expand the compounded formulation toolkit alongside established topical compounds
PT-141's agonist activity at MC4R promotes satiety by mimicking the effects of endogenous melanocortin hormones, particularly alpha-melanocyte stimulating hormone
US$ 24.11
US$ 24.00
US$ 23.46
US$ 21.16
US$ 23.41
US$ 25.79
US$ 22.14
US$ 23.09
US$ 27.09
US$ 24.57
US$ 26.83
US$ 28.11
US$ 20.83
